Disclaimer :

The Competition DG makes the information provided by the notifying parties in section 1.2 of Form CO available to the public in order to increase transparency. This information has been prepared by the notifying parties under their sole responsibility, and its content in no way prejudges the view the Commission may take of the planned operation. Nor can the Commission be held responsible for any incorrect or misleading information contained therein.

SECTION 1.2

Description of the concentration

1.1. The contemplated transaction (the "Transaction") consists in the acquisition by

Bridgepoint Advisers Group Limited through its French affiliate Bridgepoint SAS,

(“Bridgepoint") of the management company Edmond de Rothschild Capital Partners

(“EdRCP").

2.2. Bridgepoint is an independently owned private equity fund which controls a number of

entities active in a wide range of industry sectors across the EEA, including financial

services, healthcare and media. Bridgepoint SAS is active in the French segment of

small and mid-cap companies.

3.3. EdRCP is one of the Edmond de Rothschild Group’s private equity firm, dedicated to

growth LBOs in the segment of French small and mid-market companies.

4.4. Through the Transaction, Bridgepoint will acquire sole control over the three funds

currently under management of EdRCP and consequently indirectly over the 13

portfolio companies where it holds interests. The portfolio companies are active in a

wide range of sectors across the EEA and in particular healthcare products and

packaging.

5.5. The Transaction will result in a change of control of EdRCP currently controlled

exclusively by Edmond de Rothschild Private Equity Partners to the exclusive control of

Bridgepoint. It therefore constitutes a concentration under Art. 3.1(b) of Council

Regulation (EC) No 139/2004 of 20 January 2004 on the control of concentrations

between undertakings.